Mark Smithyes
Président chez Life Sciences Ontario
Profil
Mark Smithyes is currently the Chairman of Life Sciences Ontario.
He previously served as Chairman of NetraMark Holdings, Inc. in 2021, and held director positions at Medical Technology (W.B.
), Inc. and New Circles Community Services.
From 2016 to 2017, he was the Head-Pharmaceutical Business Unit at Alcon AG.
He was also the President of NetraMark Corp.
from 2021 to 2022 and the President of Labtician Thea, Inc. from 2017 to 2019.
Mr. Smithyes holds an MBA from Kellogg School of Management and an undergraduate degree from Western University.
Postes actifs de Mark Smithyes
| Sociétés | Poste | Début |
|---|---|---|
| Life Sciences Ontario | Président | - |
Anciens postes connus de Mark Smithyes
| Sociétés | Poste | Fin |
|---|---|---|
NetraMark Corp.
 NetraMark Corp. Information Technology ServicesTechnology Services Part of NetraMark Holdings, Inc., NetraMark Corp. is an AI and pharma-tech company based in Toronto, CA. NetraMark was acquired by NetraMark Holdings, Inc. on October 18, 2021 for $11.92 million. The company focuses on developing AI/ML solutions for the pharmaceutical industry, using a novel topology-based algorithm to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows NetraMark to work with much smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. NetraMark's proprietary next-generation AI solutions for pharmaceutical and biotechnology companies allow them to leverage small to large data sets in order to prevent clinical trial failure, identify biomarkers, implement adaptive trials, accelerate drug discovery, and enable drug repurposing and resurrection. The Canadian company was founded in 2016 by Joseph Geraci and Richard Brooks, with Joseph Geraci serving as CEO since then. | President | 14/07/2022 |
| NETRAMARK HOLDINGS INC. | Président | 22/11/2021 |
| Labtician Thea, Inc. | President | 01/01/2019 |
| ALCON INC. | Corporate Officer/Principal | 01/01/2017 |
| New Circles Community Services | Directeur/Membre du Conseil | - |
Formation de Mark Smithyes
| Kellogg School of Management | Masters Business Admin |
| Western University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALCON INC. | Health Technology |
| NETRAMARK HOLDINGS INC. | Technology Services |
| Entreprise privées | 5 |
|---|---|
| Medical Technology (W.B.), Inc. | |
| Life Sciences Ontario | |
NetraMark Corp.
NetraMark Corp. Information Technology ServicesTechnology Services Part of NetraMark Holdings, Inc., NetraMark Corp. is an AI and pharma-tech company based in Toronto, CA. NetraMark was acquired by NetraMark Holdings, Inc. on October 18, 2021 for $11.92 million. The company focuses on developing AI/ML solutions for the pharmaceutical industry, using a novel topology-based algorithm to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows NetraMark to work with much smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. NetraMark's proprietary next-generation AI solutions for pharmaceutical and biotechnology companies allow them to leverage small to large data sets in order to prevent clinical trial failure, identify biomarkers, implement adaptive trials, accelerate drug discovery, and enable drug repurposing and resurrection. The Canadian company was founded in 2016 by Joseph Geraci and Richard Brooks, with Joseph Geraci serving as CEO since then. | Technology Services |
| Labtician Thea, Inc. | |
| New Circles Community Services |
